A54T polymorphism in the fatty acid binding protein 2 studies in a Saudi population with type 2 diabetes mellitus

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Alharbi, Khalid Khalaf ^a   Khan, Imran Ali ^a   Bazzi, Mohammad D ^b   Al Daghri, Nasser M ^b   Hasan, Tarique N ^c   Alnbaheen, May Salem ^d,e   Alharbi, Fawiziah Khalaf ^f   Al Sheikh, Yazeed A ^a   Syed, Rabbani ^a   Aboul Soud, Mourad A M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^e SAUDI ELECTRONIC UNIVERSITY   (Saudi Arabia)

^f QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

A54T polymorphism; FABP2 gene; Saudi population; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; DNA; FATTY ACID BINDING PROTEIN 2; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; INSULIN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; DNA PURIFICATION; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; AGE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; ETHNIC GROUP; FABP2 GENE; GENDER; GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIP CIRCUMFERENCE; INSULIN BLOOD LEVEL; SAUDI; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACID-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SAUDI ARABIA;

EID: 84901314037     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-61     Document Type: Article

References (31)

1. Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population. Alharbi KK, Khan IA, Munshi A, Alharbi FK, Al-Sheikh Y, Al-Nbaheen MS, Endocrine 2014 [Epub ahead of print]
2. Metabolic benefits of Six-month Thiamine supplementation in patients with and without type 2 diabetes mellitus. Al-Attas O, Al-Daghri NM, Alokail M, Abd-Airahman S, Vinodson B, Sabico S, Clin Med Insights Endocrinol Diab 2014 7 1 6
3. CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62, 567 subjects. Li YY, Wang LS, Lu XZ, Yang ZJ, Wang XM, Zhou CW, Xu J, Qian Y, Chen AL, Sci Rep 2013 4 3 3131
4. An epidemiological study on genetic agent in type 2 diabetes mellitus. Shen HB, Shen DB, China Public Health 1999 15 492 494
5. Association between type 2 diabetes mellitus-related SNP variants and obesity trait in a Saudi population. Al-Daghri NM, Alkharfy KM, Al-Attas OS, Krishnaswamy S, Mohammed AK, Albagha OM, Alenad AM, Chrousos GP, Alokail MS, Mol Bio Rep 2014 41 1731 1740 10.1007/s11033-014-3022-z
6. prediction of incident diabetes mellitus in middle-aged adults: the Framingham offspring study. Wilson PW, Meigs JB, Sullivan X, Fox CS, Nathan DM, D'Agostino RB, Arch Intern Med 2007 167 1068 1074 10.1001/archinte.167.10.1068 17533210 (Pubitemid 46835795)
7. Association of FTO polymorphisms with obesity and obesity-related outcomes in Portuguese children. Albuquerque D, Nobrega C, Manco L, PLoS One 2013 8 1 54370 10.1371/journal.pone.0054370 23342142
8. Stratifying type 2 diabetes Cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. Perry JRB, Vought BF, Yengo L, Amin N, Dupuis J, Ganser M, Grallert H, Navarro P, Li M, Qi L, Steinthorsdottir V, Scott RA, Almgren P, Arking DE, Aulchenko Y, Balkau B, Benediktsson R, Bergman RN, Boerwinkle E, Bonnycastle L, Burtt NP, Campbell H, Charpentier G, Collins FS, Gieger C, Green T, Hadjadj S, Hattersley AT, Herder C, Hofman A, PLoS Genet 2012 8 5 1002741 10.1371/journal.pgen.1002741 22693455
9. Common variants of the liver fatty acid binding protein gene influences the risk of type 2 diabetes and insulin resistance in Spanish population. Mansego ML, Martinez F, Martinez-Larrad MT, Zabena C, Rojo G, Morcillio S, Soriquer F, Martin-Escudero JC, Serrano-Rios M, Redon J, Chaves FJ, PLoS One 2012 7 3 31853 10.1371/journal.pone.0031853 22396741
10. Tha 54 allele of fatty acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population. Tavridou A, Arvanitidis KI, Tiptiri-Kourpeti A, Petridis I, Ragia G, Kyroglou S, Christakidis D, Manolopoulos VG, Diabetes Res Clin Pract 2009 84 132 137 10.1016/j.diabres.2009.02.022 19324445
11. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Freathy RM, Mook-Kanamori DO, Sovio U, Prokopenko I, Timpson NJ, Berry DJ, Warrington NM, Widen E, Hottenga JJ, Kaakinen M, Lange LA, Bradfield JP, Kerkhof M, Marsh JA, Magi R, Chen CM, Lyon HN, Kirin M, Adair LS, Aulchenko YS, Bennett AJ, Borja JB, Bouatia-Naji N, Charoen P, Coin LJ, Cousminer DL, de Geus EJ, Deloukas P, Elliott P, McCarthy MI, Early Growth Genetics (EGG) Consortium, Nat Genet 2010 42 430 435 10.1038/ng.567 20372150
12. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazaka M, J Clin Invest 1995 95 1281 1287 10.1172/JCI117778 7883976
13. FABPS Ala54Thr polymorphism and diabetes in Chilean elders. Albala C, Villaroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Perez-Bravo F, Diabetes Res Clin Pract 2007 77 245 250 10.1016/j.diabres.2006.12.006 17292994 (Pubitemid 46680461)
14. Association of the fatty acid-binding protein 2 gene Ala54Thr polymorphism with insulin related and blood glucose: a meta-analysis in 13451 subjects. Zhao T, Zhao J, Yang W, Diabetes Metab Res Rev 2010 26 357 364 10.1002/dmrr.1085 20578207
15. Expression of rat intestinal fatty acid-binding protein in Escherichia coli: purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. Lowe JB, Sacchettini JC, Laposata M, McQuillan JJ, Gordon JI, J Biol Chem 1987 262 5931 5937 3553183
16. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A, Koyama W, Nonaka K, Diabetologia 1997 40 706 710 10.1007/s001250050737 9222651 (Pubitemid 27288117)
17. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Galluzzi JR, Cupples LA, Otvos JD, Wilson PW, Schaefer EJ, Ordovas JM, Atherosclerosis 2001 159 417 424 10.1016/S0021-9150(01)00517-2 11730822 (Pubitemid 33127255)
18. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. Guettier JM, Georgopoulos A, Tsai MY, Radha V, Shanthirani S, Deepa R, Gross M, Rao G, Mohan V, J Clin Endocrinol Metab 2005 90 1705 1711 10.1210/jc.2004-1338 15598690 (Pubitemid 40464041)
19. Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Yamada Y, Kato K, Oguri M, Yoshida T, Yokoi K, Watanabe S, Metoki N, Yoshida H, Satoh K, Ichihara S, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Nozawa Y, Int J Mol Med 2008 21 801 188 18506375
20. The T 54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. Carlsson M, Orho-Melander M, Hedenbro J, Almgren P, Groop LC, J Clin Endocrinol Metab 2000 85 2801 2804 10946885 (Pubitemid 32269155)
21. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. Sipilainen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M, J Clin Endocrinol Metab 1997 82 2629 2632 10.1210/jcem.82.8.4179 9253345 (Pubitemid 27337884)
22. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Fisher E, Li Y, Burwinkel B, Kuhr V, Hoffman K, Mohlig M, Spranqer J, Pfeiffer A, Boeing H, Schrezenmeir J, Doring F, Horm Metab Res 2006 38 341 345 10.1055/s-2006-925400 16718632 (Pubitemid 43864957)
23. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Pihlajamaki J, Rissanen J, Heikkinen S, Karjalainen L, Laakso M, Arterioscler Thromb Vasc Biol 1997 17 1039 1044 10.1161/01.ATV.17.6.1039 9194752 (Pubitemid 27260321)
24. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC, Diabetes 1999 48 150 157 10.2337/diabetes.48.1.150 9892237 (Pubitemid 29019367)
25. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. Ohrvall M, Berglund L, Salminen I, Lithell H, Aro A, Vessby B, Atherosclerosis 1996 127 65 71 10.1016/S0021-9150(96)05936-9 9006806 (Pubitemid 26425843)
26. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL, Diabetes 2005 54 3326 3330 10.2337/diabetes.54.11.3326 16249461 (Pubitemid 43334390)
27. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL, Diabetes 1999 48 1868 1872 10.2337/diabetes.48.9.1868 10480621 (Pubitemid 29415210)
28. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Ito K, Nakatani K, Fujii M, Katsuki A, Tsuchihashi K, Murala K, Goto H, Yano Y, Gabazza EC, Sumida Y, Adachi Y, Diabetes Med 1999 16 119 124 10.1046/j.1464-5491.1999.00034.x
29. The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects. Rissanen J, Pihlajamaki J, Heikkinen S, Kekalainen P, Kuusisto J, Laakso M, Diabetes 1997 46 711 712 10.2337/diab.46.4.711 9075815 (Pubitemid 27143391)
30. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians. Chiu KC, Chuang LM, Yoon C, BMC Genet 2001 2 7 11299043
31. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects. Weiss EP, Brown MD, Shuldiner AR, Hagberg JM, Physiol Genom 2002 10 145 157 (Pubitemid 135707437)